The 23 cases of PML was identified by the EMEA in their monthly meeting minutes. The EMEA is the European equivalent of the FDA.

The financial press is doing MS patients no favours as they tend to sentionalize the news rather than giving it detailed research and balanced reporting.

As far as outcomes from the PML infections, I do believe the outcomes have been better than expected but they still run the gamut from death/severe disability to only minor remnant effects. We haven't seen much info from the more recent April 09 to present cases which may be a better indicator of outcomes (been looking for PML more vigorously).

Chris